Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 5, 2007, Pages

  Welch, William J ^a   Patel, Kinjal ^a   Modlinger, Paul ^a   Mendonca, Margarida ^a   Kawada, Noritaka ^a   Dennehy, Kathryn ^a   Aslam, Shakil ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibition; Isoprostane; Renovascular hypertension; Thromboxane A 2

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; BENAZEPRILAT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; LOSARTAN; MALONALDEHYDE; PROSTAGLANDIN; PROSTANOID RECEPTOR; RENIN; THROMBOXANE RECEPTOR; THROMBOXANE RECEPTOR BLOCKING AGENT; VALDECOXIB; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CLIP; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RENOVASCULAR HYPERTENSION; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYPERTENSION; MALE; MEMBRANE PROTEINS; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, THROMBOXANE; VASOCONSTRICTION;

EID: 36148984187     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00748.2007     Document Type: Article

References (48)

1. Anderson CB, Tannenbaum JS, Sicard GA, Etheredge EE. Renal thromboxane synthesis in excised kidney distal to renovascular lesions. JAMA 251: 3118-3120, 1984.
2. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
3. Cheng HF, Wang SW, Zhang MZ, McKanna JA, Breyer R, Harris RC. Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1. Am J Physiol Regul Integr Comp Physiol 283: R638-R646, 2002.
4. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345: 433-442, 2001.
5. 2 receptor activation in rats. Am J Physiol Heart Circ Physiol 273: H734-H739, 1997.
6. Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF. Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 284: F498-F502, 2003.
7. Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 255: 6253-6261, 1980.
8. Himmelstein SI, Klotman PE. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am J Physiol Renal Fluid Electrolyte Physiol 257: F190-F196, 1989.
9. Hiyoshi H, Yayama K, Takano M, Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 45: 967-973, 2005.
10. Imanishi M, Kawamura M, Akabane S, Matsushima Y, Kuramochi M, Ito K, Ohta M, Kimura K, Takamiya M, Omae T. Aspirin lowers blood pressure in patients with renovascular hypertension. Hypertension 14: 461-468, 1989.
11. Imanishi M, Ohta M, Kawamura M, Akabane S, Matsushima Y, Kuramochi M, Kojima S, Kimura K, Takamiya M, Ito K, Omae T. Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension. Am J Hypertens 4: 761-768, 1991.
12. Imig JD, Kitiyakara C, Wilcox CS. Arachidonate metabolites. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW and Giebisch G. New York: Raven, 2000, p. 875-889.
13. Jackson EK, Oates JA, Branch RA. Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation. Circ Res 49: 180-185, 1981.
14. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
15. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002.
16. Kawada N, Solis G, Ivey N, Connors S, Dennehy K, Modlinger P, Hamel R, Kawada JT, Imai E, Langenbach R, Welch W, Wilcox CS. Cyclooxygenase-1- deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction. Hypertension 45: 1131-1138, 2005.
17. Kim S, Iwao H, Nakamura N, Ikemoto F, Yamamoto K. Fate of circulating renin in conscious rats. Am J Physiol Endocrinol Metab 252: E136-E146, 1987.
18. Kitiyakara C, Welch WJ, Verbalis JG, Wilcox CS. Role of thromboxane receptors in the dipsogenic response to central angiotensin II. Am J Physiol Regul Integr Comp Physiol 282: R865-R869, 2002.
19. Kopkan L, Majid DS. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension 47: 568-572, 2006.
20. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension 31: 487-492, 1998.
21. Lin L, Mistry M, Stier CT Jr, Nasjletti A. Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension 17: 517-525, 1991.
22. Lin L, Nasjletti A. Role of endothelium-derived prostaglandin in angiotensin-induced vasoconstriction. Hypertension 18: 158-164, 1991.
23. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, Sterzel RB. Angiotensin-induced hypertension in the rat: sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
24. Mardini IA, FitzGerald GA. Selective inhibitors of cyclooxygenase-2. A growing class of anti-inflammatory drugs. Mol Interv 1: 30-38, 2001.
25. Mistry M, Nasjletti A. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. J Pharmacol Exp Ther 253: 90-94, 1990.
26. Okumura T, Hayashi I, Ikezawa T, Yamanaka M, Takata T, Fujita Y, Saigenji K, Yamashina S, Majima M. Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension. Hypertens Res 25: 927-938, 2002.
27. Pidgeon GP, Tamosiuniene R, Chen G, Leonard I, Belton O, Bradford A, Fitzgerald DJ. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation 110: 2701-2707, 2004.
28. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
29. Roberts LJ, Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1345: 121-135, 1997.
30. - and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000.
31. Siragy HM, Carey RM. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33: 1237-1242, 1999.
32. Stahl RAK, Helmchen U, Paravicini M, Ritter LJ, Schollmeyer P. Glomerular prostaglandin formation in two-kidney, one-clip hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 247: F975-F981, 1984.
33. Stichtenoth DO, Frolich JC. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs 63: 33-45, 2003.
34. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
35. Valentin F, Field M, Tippins JR. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 279: 8316-8324, 2004.
36. Wang JL, Cheng HF, Harris RC. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101, 1999.
37. Welch WJ, Ahlstrom NG, Wilcox CS. Mechanism of hypertension during prolonged infusion of thromboxane mimetic. Eur J Int Med 2: 277-280, 1992.
38. 1 receptors in renal hemodynamics and oxygenation in the post-clipped 2K,1C kidney. Hypertension 41: 692-696, 2003.
39. Welch WJ, Wilcox CS. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat. J Clin Invest 81: 1843-1849, 1988.
40. Welch WJ, Wilcox CS. Feedback responses during sequential inhibition of angiotensin and thromboxane. Am J Physiol Renal Fluid Electrolyte Physiol 258: F457-F466, 1990.
41. Welch WJ, Wilcox CS. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 89: 1857-1865, 1992.
42. Welch WJ, Wilcox CS, Dunbar KR. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic. Am J Physiol Renal Fluid Electrolyte Physiol 257: F554-F560, 1989.
43. 2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol 271: R891-R896, 1996.
44. Wilcox CS, Folger WH, Welch WJ. Renal vasoconstriction with U-46,619: role of arachidonate metabolites. J Am Soc Nephrol 5: 1120-1124, 1994.
45. 2 receptors. Am J Physiol Heart Circ Physiol 273: H1927-H1932, 1997.
46. Wilcox CS, Lin L. Vasoconstrictor prostaglandins in angiotensin-dependent and renovascular hypertension. J Nephrol 6: 124-133, 1993.
47. Wilcox CS, Welch WJ. Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens 3: 242-249, 1990.
48. Wilcox CS, Welch WJ, Snellen H. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090-1097, 1991.